Announcements

Showing items 5121 - 5130 of 6014 stories.

Decoding COVID-19 through data: WVU team builds patient registry to harness research, predict outcomes

Even before West Virginia reported its first case of the novel coronavirus, Dr. Sally Hodder and her team recognized the need for a COVID-19 patient data registry. It was after attending a January conference at the National Institutes of Health when Hodder, an infectious disease specialist who lived through the 1980s AIDS/HIV epidemic, predicted with confidence that we’d soon have a pandemic on our hands.

WVU Medicine receives FDA Investigational Drug Approval for COVID-19 immunotherapy

WVU Medicine pediatric and adult allergist and immunologist Brian Peppers, D.O., Ph.D., has received Investigational New Drug approval from the U.S. Food and Drug Administration for the experimental treatment of COVID-19 using convalescent donor plasma. This is the first FDA approved Investigational New Drug trial for COVID-19 immunotherapy to include pediatric patients.